MSH2 and small cell lung carcinoma: By incorporating a conditional Msh2 knockout allele into the RP model, we generated a preclinical model (RPM) that mimics the MMR mutational signature and high TMB as observed in 15% of SCLC clinical cases in a recent study (Liu et al. 2024).